X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1255) 1255
Patent (1074) 1074
Publication (45) 45
Conference Proceeding (41) 41
Book Chapter (12) 12
Web Resource (5) 5
Book / eBook (4) 4
Dissertation (2) 2
Report (1) 1
Technical Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
physics (495) 495
humans (397) 397
chemistry (349) 349
metallurgy (344) 344
electricity (278) 278
human necessities (240) 240
index medicus (226) 226
male (223) 223
female (210) 210
hygiene (184) 184
medical or veterinary science (184) 184
animals (177) 177
preparations for medical, dental, or toilet purposes (173) 173
optics (170) 170
measuring (166) 166
testing (166) 166
organic chemistry (163) 163
specific therapeutic activity of chemical compounds ormedicinal preparations (160) 160
biochemistry (153) 153
heating (152) 152
lighting (151) 151
blasting (150) 150
mechanical engineering (150) 150
microbiology (150) 150
weapons (150) 150
middle aged (145) 145
beer (144) 144
enzymology (144) 144
mutation or genetic engineering (144) 144
spirits (144) 144
vinegar (144) 144
wine (144) 144
culture media (139) 139
compositions thereof (137) 137
microorganisms or enzymes (137) 137
peptides (137) 137
propagating, preserving or maintaining microorganisms (137) 137
oncology (135) 135
basic electric elements (133) 133
aged (131) 131
adult (128) 128
performing operations (128) 128
transporting (128) 128
general tagging of cross-sectional technologies spanning over several sections of the ipc (111) 111
general tagging of new technological developments (111) 111
investigating or analysing materials by determining theirchemical or physical properties (111) 111
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (111) 111
cinematography (108) 108
electrography (108) 108
holography (108) 108
photography (108) 108
mice (103) 103
immunotherapy (100) 100
devices or arrangements, the optical operation of which ismodified by changing the optical properties of the medium of thedevices or arrangements for the control of the intensity,colour, phase, polarisation or direction of light, e.g.switching, gating, modulating or demodulating (98) 98
frequency-changing (98) 98
non-linear optics (98) 98
optical analogue/digital converters (98) 98
optical logic elements (98) 98
techniques or procedures for the operation thereof (98) 98
optical elements, systems, or apparatus (89) 89
compositions or test papers therefor (87) 87
condition-responsive control in microbiological orenzymological processes (87) 87
measuring or testing processes involving enzymes, nucleicacids or microorganisms (87) 87
processes of preparing such compositions (87) 87
electric communication technique (84) 84
immunology (76) 76
agriculture (75) 75
electric solid state devices not otherwise provided for (72) 72
fishing (72) 72
forestry (72) 72
semiconductor devices (72) 72
animal husbandry (71) 71
hunting (71) 71
trapping (71) 71
cancer (70) 70
electrophotography (69) 69
magnetography (69) 69
technical subjects covered by former uspc (66) 66
identification (61) 61
care of birds, fishes, insects (60) 60
electric techniques not otherwise provided for (60) 60
expression (60) 60
new breeds of animals (60) 60
rearing or breeding animals, not otherwise provided for (60) 60
medicine, research & experimental (55) 55
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (54) 54
dyes (52) 52
melanoma - immunology (52) 52
adhesives (51) 51
miscellaneous applications of materials (51) 51
miscellaneous compositions (51) 51
natural resins (51) 51
paints (51) 51
polishes (51) 51
technical subjects covered by former us classification (49) 49
antigens, neoplasm - immunology (47) 47
casings or constructional details of electric apparatus (46) 46
cell line, tumor (46) 46
manufacture of assemblages of electrical components (46) 46
molecular sequence data (46) 46
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2250) 2250
French (192) 192
Japanese (188) 188
German (131) 131
Chinese (81) 81
Korean (14) 14
Portuguese (8) 8
Spanish (7) 7
Finnish (5) 5
Swedish (5) 5
Danish (3) 3
Italian (3) 3
Russian (3) 3
Indonesian (1) 1
Polish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Anand, Sonia S and Bosch, Jackie and Eikelboom, John W and Connolly, Stuart J and Diaz, Rafael and Widimsky, Peter and Aboyans, Victor and Alings, Marco and Kakkar, Ajay K and Keltai, Katalin and Maggioni, Aldo P and Lewis, Basil S and Störk, Stefan and Zhu, Jun and Lopez-Jaramillo, Patricio and O'Donnell, Martin and Commerford, Patrick J and Vinereanu, Dragos and Pogosova, Nana and Ryden, Lars and Fox, Keith A A and Bhatt, Deepak L and Misselwitz, Frank and Varigos, John D and Vanassche, Thomas and Avezum, Alvaro A and Chen, Edmond and Branch, Kelley and Leong, Darryl P and Bangdiwala, Shrikant I and Hart, Robert G and Yusuf, Salim and SALA, JORGELINA and CARTASEGNA, LUIS and VICO, MARISA and HOMINAL, MIGUEL ANGEL and HASBANI, EDUARDO and CACCAVO, ALBERTO and ZAIDMAN, CESAR and VOGEL, DANIEL and HRABAR, ADRIAN and SCHYGIEL, PABLO OMAR and CUNEO, CARLOS and LUQUEZ, HUGO and MACKINNON, IGNACIO J and AHUAD GUERRERO, RODOLFO ANDRES and COSTABEL, JUAN PABLO and BARTOLACCI, INES PALMIRA and MONTANA, OSCAR and BARBIERI, MARIA and GOMEZ VILAMAJO, OSCAR and GARCIA DURAN, RUBEN OMAR and SCHIAVI, LILIA BEATRIZ and GARRIDO, MARCELO and INGARAMO, ADRIAN and BORDONAVA, ANSELMO PAULINO and PELAGAGGE, MARIA JOSE and NOVARETTO, LEONARDO and ALBISU DI GENNERO, JUAN PABLO and IBANEZ SAGGIA, LUZ MARIA and ALVAREZ, MOIRA and VITA, NESTOR ALEJANDRO and MACIN, STELLA MARIS and DRAN, RICARDO DARIO and CARDONA, MARCELO and GUZMAN, RANDOLPH and GUZMAN, LUIS and SARJANOVICH, RODOLFO JUAN and CUADRADO, JESUS and NANI, SEBASTIAN and LITVAK BRUNO, MARCOS RAUL and CHACON, CAROLINA and MAFFEI, LAURA ELENA and GRINFELD, DIEGO and VENSENTINI, NATALIA and MAJUL, CLAUDIO RODOLFO and LUCIARDI, HECTOR LUCAS and GONZALEZ COLASO, PATRICIA DEL CARMEN and FERRE PACORA, FREDY ANTONI and VAN DEN HEUVEL, PAUL and VERHAMME, PETER and ECTOR, BAVO and DEBONNAIRE, PHILIPPE and VAN DE BORNE, PHILIPPE and LEROY, JEAN and SCHROE, HERMAN and VRANCKX, PASCAL and ELEGEERT, IVAN and HOFFER, ETIENNE and DUJARDIN, KARL and INDIO DO BRASIL, CLARISSE and PRECOMA, DALTON and ABRANTES, JOSE ANTONIO and MANENTI, EULER and REIS, GILMAR and SARAIVA, JOSE and MAIA, LILIA and HERNANDES, MAURO and ROSSI, PAULO and ROSSI DOS SANTOS, FABIO and ... and COMPASS Investigators and Sahlgrenska akademin and Institute of Medicine, Department of Molecular and Clinical Medicine and Institutionen för medicin, avdelningen för molekylär och klinisk medicin and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
The Lancet, ISSN 0140-6736, 01/2018, Volume 391, Issue 10117, pp. 219 - 229
Patients with peripheral artery disease have an increased risk of cardiovascular morbidity and mortality. Antiplatelet agents are widely used to reduce these... 
MORTALITY | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | MANAGEMENT | THERAPY | OUTPATIENTS | CARDIOVASCULAR EVENT RATES | PREVENTION | RISK | Myocardial Infarction - epidemiology | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Carotid Artery Diseases - complications | Male | Peripheral Arterial Disease - complications | Rivaroxaban - administration & dosage | Aspirin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Incidence | Dose-Response Relationship, Drug | Rivaroxaban - adverse effects | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Aspirin - therapeutic use | Lower Extremity - surgery | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Myocardial Infarction - etiology | Rivaroxaban - therapeutic use | Carotid Artery Diseases - drug therapy | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Double-Blind Method | Drug Administration Schedule | Peripheral Arterial Disease - drug therapy | Carotid Artery Diseases - epidemiology | Morbidity | Factor Xa Inhibitors - therapeutic use | Stroke - etiology | Peripheral Arterial Disease - epidemiology | Factor Xa Inhibitors - adverse effects | Aged | Myocardial Infarction - prevention & control | Amputation - statistics & numerical data | Hemorrhage - chemically induced | Lower Extremity - blood supply | Cardiac arrhythmia | Anticoagulants | Aspirin | Stroke | Heart attacks | Medical imaging | Mortality | Clinical trials | Cardiovascular disease | Patients | Disease control | Carotid arteries | Disease prevention | Coronary vessels | Blood pressure | Carotid artery | Acute coronary syndromes | Thromboembolism | Health risk assessment | Cardiovascular Diseases | Factor Xa Inhibitors | Klinisk medicin | Hemorrhage | epidemiology | Rivaroxaban | administration & dosage | Combination | Amputation | Drug | drug therapy | chemically induced | complications | prevention & control | Peripheral Arterial Disease | etiology | Clinical Medicine | Myocardial Infarction | statistics & numerical data | blood supply | Carotid Artery Diseases | Platelet Aggregation Inhibitors | adverse effects | mortality | Lower Extremity | Dose-Response Relationship | therapeutic use | surgery
Journal Article
[Rinsho ketsueki] The Japanese journal of clinical hematology, ISSN 0485-1439, 2018, Volume 59, Issue 7, p. 939
Clinical trials for immune-checkpoint inhibitors and T cell-based adoptive cell therapy have demonstrated robust clinical responses in some patients with... 
Neoplasms - therapy | B7-H1 Antigen | Neoplasms - immunology | Cancer Vaccines | Humans | Immunotherapy | Tumor Microenvironment | Programmed Cell Death 1 Receptor
Journal Article
by Connolly, Stuart J and Eikelboom, John W and Bosch, Jackie and Dagenais, Gilles and Dyal, Leanne and Lanas, Fernando and Metsarinne, Kaj and O'Donnell, Martin and Dans, Anthony L and Ha, Jong-Won and Parkhomenko, Alexandr N and Avezum, Alvaro A and Lonn, Eva and Lisheng, Liu and Torp-Pedersen, Christian and Widimsky, Petr and Maggioni, Aldo P and Felix, Camilo and Keltai, Katalin and Hori, Masatsugu and Yusoff, Khalid and Guzik, Tomasz J and Bhatt, Deepak L and Branch, Kelley R H and Cook Bruns, Nancy and Berkowitz, Scott D and Anand, Sonia S and Varigos, John D and Fox, Keith A A and Yusuf, Salim and SALA, JORGELINA and CARTASEGNA, LUIS and VICO, MARISA and HOMINAL, MIGUEL ANGEL and HASBANI, EDUARDO and CACCAVO, ALBERTO and ZAIDMAN, CESAR and VOGEL, DANIEL and HRABAR, ADRIAN and SCHYGIEL, PABLO OMAR and CUNEO, CARLOS and LUQUEZ, HUGO and MACKINNON, IGNACIO J and AHUAD GUERRERO, RODOLFO ANDRES and COSTABEL, JUAN PABLO and BARTOLACCI, INES PALMIRA and MONTANA, OSCAR and BARBIERI, MARIA and GOMEZ VILAMAJO, OSCAR and GARCIA DURAN, RUBEN OMAR and SCHIAVI, LILIA BEATRIZ and GARRIDO, MARCELO and INGARAMO, ADRIAN and BORDONAVA, ANSELMO PAULINO and PELAGAGGE, MARIA JOSE and NOVARETTO, LEONARDO and ALBISU DI GENNERO, JUAN PABLO and IBANEZ SAGGIA, LUZ MARIA and ALVAREZ, MOIRA and VITA, NESTOR ALEJANDRO and MACIN, STELLA MARIS and DRAN, RICARDO DARIO and CARDONA, MARCELO and GUZMAN, RANDOLPH and GUZMAN, LUIS and SARJANOVICH, RODOLFO JUAN and CUADRADO, JESUS and NANI, SEBASTIAN and LITVAK BRUNO, MARCOS RAUL and CHACON, CAROLINA and MAFFEI, LAURA ELENA and GRINFELD, DIEGO and VENSENTINI, NATALIA and MAJUL, CLAUDIO RODOLFO and LUCIARDI, HECTOR LUCAS and GONZALEZ COLASO, PATRICIA DEL CARMEN and FERRE PACORA, FREDY ANTONI and VAN DEN HEUVEL, PAUL and VERHAMME, PETER and ECTOR, BAVO and DEBONNAIRE, PHILIPPE and VAN DE BORNE, PHILIPPE and LEROY, JEAN and SCHROE, HERMAN and VRANCKX, PASCAL and ELEGEERT, IVAN and HOFFER, ETIENNE and DUJARDIN, KARL and INDIO DO BRASIL, CLARISSE and PRECOMA, DALTON and ABRANTES, JOSE ANTONIO and MANENTI, EULER and REIS, GILMAR and SARAIVA, JOSE and MAIA, LILIA and HERNANDES, MAURO and ROSSI, PAULO and ROSSI DOS SANTOS, FABIO and ZIMMERMANN, SERGIO LUIZ and RECH, RAFAEL and ... and COMPASS Investigators and COMPASS investigators and Sahlgrenska akademin and Institute of Medicine, Department of Molecular and Clinical Medicine and Institutionen för medicin, avdelningen för molekylär och klinisk medicin and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
The Lancet, ISSN 0140-6736, 01/2018, Volume 391, Issue 10117, pp. 205 - 218
Coronary artery disease is a major cause of morbidity and mortality worldwide, and is a consequence of acute thrombotic events involving activation of... 
PREVENTION | MEDICINE, GENERAL & INTERNAL | ORAL RIVAROXABAN | Myocardial Infarction - epidemiology | Cardiovascular Diseases - prevention & control | Humans | Male | Rivaroxaban - administration & dosage | Aspirin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Dose-Response Relationship, Drug | Rivaroxaban - adverse effects | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Aspirin - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Rivaroxaban - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Double-Blind Method | Drug Administration Schedule | Coronary Artery Disease - drug therapy | Morbidity | Factor Xa Inhibitors - therapeutic use | Factor Xa Inhibitors - adverse effects | Aged | Coronary Artery Disease - epidemiology | Myocardial Infarction - prevention & control | Hemorrhage - chemically induced | Anticoagulants | Aspirin | Stroke | Heart attacks | Mortality | Coronary artery | Clinical trials | Cardiovascular disease | Coronary artery disease | Disease control | Disease prevention | Coronary vessels | Acute coronary syndromes | Thromboembolism | Health risk assessment | Drug therapy | Heart diseases | Cardiovascular Diseases | Factor Xa Inhibitors | Klinisk medicin | Hemorrhage | epidemiology | Rivaroxaban | administration & dosage | Combination | Drug | drug therapy | chemically induced | prevention & control | Coronary Artery Disease | Clinical Medicine | Myocardial Infarction | Platelet Aggregation Inhibitors | adverse effects | mortality | Dose-Response Relationship | therapeutic use
Journal Article
Nihon rinsho. Japanese journal of clinical medicine, ISSN 0047-1852, 02/2017, Volume 75, Issue 2, p. 175
Cancer immunotherapy began as a Coley's vaccine, and then, non-specific immuno- modulators, anti-tumor monoclonal antibody, cytokines, cancer vaccine (e.g.... 
Neoplasms - therapy | Neoplasms - immunology | Humans | Immunotherapy
Journal Article
Journal of Translational Medicine, ISSN 1479-5876, 10/2012, Volume 10, Issue 1, pp. 205 - 205
Journal Article
[Rinshō ketsueki] The Japanese journal of clinical hematology, ISSN 0485-1439, 10/2015, Volume 56, Issue 10, pp. 2186 - 2194
Journal Article
[Rinsho ketsueki] The Japanese journal of clinical hematology, ISSN 0485-1439, 10/2015, Volume 56, Issue 10, p. 2186
As cancer immunotherapies utilizing anti-tumor T-cell responses, immuno-checkpoint blockade and adoptive T-cell immunotherapy have recently achieved durable... 
Immunotherapy - methods | Neoplasms - therapy | Neoplasms - immunology | Humans | T-Lymphocytes - immunology | Programmed Cell Death 1 Receptor - immunology | CTLA-4 Antigen - immunology | Precision Medicine
Journal Article
PLOS ONE, ISSN 1932-6203, 01/2016, Volume 11, Issue 1, p. e0146371
The homeobox protein, PEPP2 (RHOXF2), has been suggested as a cancer/testis (CT) antigen based on its expression pattern. However, the peptide epitope of PEPP2... 
IMMUNE-RESPONSE | STEM-CELLS | GENE | IMMUNOTHERAPY | MULTIDISCIPLINARY SCIENCES | MYELOID-LEUKEMIA | ANTIGENS | INDUCTION | MINIMAL RESIDUAL DISEASE | CANCER | T-LYMPHOCYTES | HLA-A24 Antigen - immunology | Homeodomain Proteins - metabolism | Humans | Leukemia, Myeloid - genetics | Cells, Cultured | Azacitidine - analogs & derivatives | Decitabine | Monocytes - metabolism | Homeodomain Proteins - immunology | Case-Control Studies | Homeodomain Proteins - genetics | Epitopes - immunology | Monocytes - drug effects | Azacitidine - pharmacology | T-Lymphocytes, Cytotoxic - drug effects | Neoplastic Stem Cells - metabolism | T-Lymphocytes, Cytotoxic - metabolism | Cell Line, Tumor | Care and treatment | Histocompatibility antigens | Myelocytic leukemia | Immunotherapy | HLA histocompatibility antigens | Physiological aspects | Genetic aspects | Nonlymphoid leukemia | Research | T cells | Target recognition | Leukemia | Cytotoxicity | Leukocytes (mononuclear) | Identification | Lymphocytes T | Kinases | Cancer therapies | Homeobox | Lymphocytes | DNA methylation | Bone marrow | Physiology | Deoxyribonucleic acid--DNA | Antigens | Hematology | Myeloid leukemia | Pattern recognition | Gene expression | Chemotherapy | Medical prognosis | Pharmacy | Stem cells | Epigenetics | Combined treatment | Histocompatibility antigen HLA | Cancer | Deoxyribonucleic acid | DNA
Journal Article